<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1252">
 <bold>Conclusions:</bold> UV-C technology has demonstrated its effectiveness in critical clinical variables of patients in the ICU, such as presence of S. aureus in lungs, incidence of sepsis, or need of &gt;48Â hours of mechanical ventilation. Moreover, the UVAS contributed to reduce the 30-day mortality rate.
</p>
